Autopsy report · NCT03136510

Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban

“not enough patients”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 months after it had already started.
• Ran for about 2 years 6 months before it stopped.
• 12 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Hopital Lariboisière

Sponsor type

University, hospital or other

Conditions

Coagulation Disorder; Non Valvular Atrial Fibrillation

Interventions

Apixaban 5 mg

Participants

12

Sites

1

Countries

France

Trials that died the same way

• Ridge Preservation Comparing Simultaneous vs. Delayed Grafting
  “Not enough patients available” (95% match in meaning)
• Epidermal Cells Delivery and Acute Burns
  “Not enough patients included” (93% match in meaning)
• The Antidepressant Effect of Right Temporal Low Frequency rTMS Compared to Sham
  “Too few patients included” (85% match in meaning)
• Pyrexia Management Using an IL-6 Antibody in BRAF+ Melanoma Patients Treated with Dabrafenib/ Trametinib +/- Immunotherapy
  “too few patients could be included” (83% match in meaning)
• REEDUCATION OF OLFACTORY DISORDERS AFTER A CEREBRAL VASCULAR ACCIDENT IN ADULTS
  “lack of patients” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.